C5L2: A controversial receptor of complement anaphylatoxin, C5a

FASEB Journal

Volumn 27, Issue 3, 2013, Pages 855-864

  Li, Rui ^a   Coulthard, Liam G ^a   Wu, M C L ^a   Taylor, Stephen M ^a   Woodruff, Trent M ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Inflammation; Therapeutics

Indexed keywords

BETA ARRESTIN; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5L2; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; ASTHMA; CYTOKINE RELEASE; HUMAN; METABOLISM; MOLECULAR BIOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; SEPSIS; SIGNAL TRANSDUCTION;

ANIMALS; ARRESTINS; COMPLEMENT C5A; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMANS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CHEMOKINE; RECEPTORS, COMPLEMENT; SEPSIS; SIGNAL TRANSDUCTION;

EID: 84874623794     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-220509     Document Type: Article

References (58)

1. Woodruff, T. M., Nandakumar, K. S., and Tedesco, F. (2011) Inhibiting the C5-C5a receptor axis. Mol. Immunol. 48, 1631-1642
2. Monk, P. N., Scola, A.-M., Madala, P., and Fairlie, D. P. (2007) Function, structure and therapeutic potential of complement C5a receptors. Br. J. Pharmacol. 152, 429-448 (Pubitemid 47585036)
3. Ohno, M., Hirata, T., Enomoto, M., Araki, T., Ishimaru, H., and Takahashi, T. A. (2000) A putative chemoattractant receptor, C5L2, is expressed in granulocyte and immature dendritic cells, but not in mature dendritic cells. Mol. Immunol. 37, 407-412
4. Cain, S. A., and Monk, P. N. (2002) The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74). J. Biol. Chem. 277, 7165-7169 (Pubitemid 34953106)
5. Cui, W., Simaan, M., Laporte, S., Lodge, R., and Cianflone, K. (2009) C5a- and ASP-mediated C5L2 activation, endocytosis and recycling are lost in S323I-C5L2 mutation. Mol. Immunol. 46, 3086-3098
6. Johswich, K., Martin, M., Thalmann, J., Rheinheimer, C., Monk, P. N., and Klos, A. (2006) Ligand specificity of the anaphylatoxin C5L2 receptor and its regulation on myeloid and epithelial cell lines. J. Biol. Chem. 281, 39088-39095 (Pubitemid 46041868)
7. Prossnitz, E. R., Gilbert, T. L., Chiang, S., Campbell, J. J., Qin, S., Newman, W., Sklar, L. A., and Ye, R. D. (1999) Multiple activation steps of the N-formyl peptide receptor. Biochemistry 38, 2240-2247
8. Okinaga, S., Slattery, D., Humbles, A., Zsengeller, Z., Morteau, O., Kinrade, M. B., Brodbeck, R. M., Krause, J. E., Choe, H. R., Gerard, N. P., and Gerard, C. (2003) C5L2, a nonsignaling C5A binding protein. Biochemistry 42, 9406-9415 (Pubitemid 36959248)
9. He, R., Browning, D. D., and Ye, R. D. (2001) Differential roles of the NPXXY motif in formyl peptide receptor signaling. J. Immunol. 166, 4099-4105 (Pubitemid 32224941)
10. Scola, A.-M., Higginbottom, A., Partridge, L. J., Reid, R. C., Woodruff, T., Taylor, S. M., Fairlie, D. P., and Monk. P. N. (2007) The role of the N-terminal domain of the complement fragment receptor C5L2 in ligand binding. J. Biol. Chem. 282, 3664-3671 (Pubitemid 47084475)
11. Buck, E., Bourne, H., and Wells, J. A. (2005) Site-specific disulfide capture of agonist and antagonist peptides on the C5a receptor. J. Biol. Chem. 280, 4009-4012 (Pubitemid 40288561)
12. Chen, N. J., Mirtsos, C., Suh, D., Lu, Y. C., Lin, W. J., McKerlie, C., Lee, T., Baribault, H., Tian, H., and Yeh, W. C. (2007) C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a. Nature 446, 203-207 (Pubitemid 46398661)
13. Gao, H., Neff, T. A., Guo, R. F., Speyer, C. L., Sarma, J. V., Tomlins, S., Man, Y., Riedemann, N. C., Hoesel, L. M., Younkin, E., Zetoune, F. S., and Ward, P. A. (2005) Evidence for a functional role of the second C5a receptor C5L2. FASEB J. 19, 1003-1005 (Pubitemid 40827732)
14. Kalant, D., MacLaren, R., Cui, W., Samanta, R., Monk, P. N., Laporte, S. A., and Cianflone, K. (2005) C5L2 is a functional receptor for acylation-stimulating protein. J. Biol. Chem. 280, 23936-23944 (Pubitemid 40884882)
15. Gavrilyuk, V., Kalinin, S., Hilbush, B. S., Middlecamp, A., McGuire, S., Pelligrino, D., Weinberg, G., and Feinstein, D. L. (2005) Identification of complement 5a-like receptor (C5L2) from astrocytes: characterization of anti-inflammatory properties. J. Neurochem. 92, 1140-1149 (Pubitemid 40344304)
16. Woodruff, T. M., Costantini, K. J., Crane, J. W., Atkin, J. D., Monk, P. N., Taylor, S. M., and Noakes, P. G. (2008) The complement factor C5a contributes to pathology in a rat model of amyotrophic lateral sclerosis. J. Immunol. 181, 8727-8734
17. Van Werkhoven, M. B., Damman, J., Daha, M. R., Krikke, C., van Goor, H., van Son, W. J., Hillebrands, J. L., van Dijk, M. C., and Seelen, M. A. (2013) Novel insights in localization and expression levels of C5aR and C5L2 under native and post-transplant conditions in the kidney. Mol. Immunol. 53, 237-245
18. Bamberg, C. E., Mackay, C. R., Lee, H., Zahra, D., Jackson, J., Lim, Y. S., Whitfeld, P. L., Craig, S., Corsini, E., Lu, B., Gerard, C., and Gerard, N. P. (2010) The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction. J. Biol. Chem. 285, 7633-7644
19. Otto, M., Hawlisch, H., Monk, P. N., Müller, M., Klos, A., Karp, C. L., and Köhl, J. (2004) C5a mutants are potent antagonists of the C5a receptor (CD88) and of C5L2: position 69 is the locus that determines agonism or antagonism. J. Biol. Chem. 279, 142-151 (Pubitemid 38044809)
20. Scola, A.-M., Johswich, K.-O., Morgan, B. P., Klos, A., and Monk, P. N. (2009) The human complement fragment receptor, C5L2, is a recycling decoy receptor. Mol. Immunol. 46, 1149-1162
21. Huber-Lang M., Sarma, J. V., Rittirsch, D., Schreiber, H., Weiss, M., Flierl, M., Younkin, E., Schneider, M., Suger-Wiedeck, H., Gebhard, F., McClintock, S. D., Neff, T., Zetoune, F., Bruckner, U., Guo, R. F., Monk, P. N., and Ward, P. A. (2005) Changes in the novel orphan, C5a receptor (C5L2), during experimental sepsis and sepsis in humans. J. Immunol. 174, 1104-1110 (Pubitemid 40094308)
22. Rittirsch, D., Flierl, M. A., Nadeau, B. A., Day, D. E., Huber- Lang, M., Mackay, C. R., Zetoune, F. S., Gerard, N. P., Cianflone, K., Köhl, J., Gerard, C., Sarma, J. V., and Ward, P. A. (2008) Functional roles for C5a receptors in sepsis. Nat. Med. 14, 551-557 (Pubitemid 351655216)
23. Peng, Q., Li, K., Wang, N., Li, Q., Asgari, E., Lu, B., Woodruff, T. M, Sacks, S. H., and Zhou, W. (2009) Dendritic cell function in allostimulation is modulated by C5aR signaling. J. Immunol. 183, 6058-6068
24. Raby, A. C., Holst, B., Davies, J., Colmont, C., Laumonnier, Y., Coles, B., Shah, S., Hall, J., Topley, N., Köhl, J., Morgan, B. P., Labéta, M. O. (2011) TLR activation enhances C5a-induced pro-inflammatory responses by negatively modulating the second C5a receptor, C5L2. Eur. J. Immunol. 41, 2741-2752
25. Huber-Lang, M., Sarma, J. V., Zetoune, F. S., Rittirsch, D., Neff, T. A., McGuire, S. R., Lambris, J. D., Warner, R. L., Flierl, M. A., Hoesel, L. M., Gebhard, F., Younger, J. G., Drouin, S. M., Wetsel, R. A., and Ward, P. A. (2006) Generation of C5a in the absence of C3: a new complement activation pathway. Nat. Med. 12, 682-687 (Pubitemid 43865238)
26. MacLaren, R., Kalant, D., and Cianflone, K. (2007) The ASP receptor C5L2 is regulated by metabolic hormones associated with insulin resistance. Biochem. Cell Biol. 85, 11-21 (Pubitemid 46877384)
27. Liu, H.-B., Cui, N.-Q., Wang, Q., Li, D.-H., and Xue, X.-P. (2008) Sphingosine-1-phosphate and its analogue FTY720 diminish acute pulmonary injury in rats with acute necrotizing pancreatitis. Pancreas 36, e10-e15 (Pubitemid 351440947)
28. McVerry, B. J., and Garcia, J. G. N. (2004) Endothelial cell barrier regulation by sphingosine 1-phosphate. J. Cell. Biochem. 92, 1075-1085 (Pubitemid 44264219)
29. McVerry, B. J., Peng, X., Hassoun, P. M., Sammani, S., Simon, B. A., and Garcia, J. G. (2004) Sphingosine 1-phosphate reduces vascular leak in murine and canine models of acute lung injury. Am. J. Respir. Crit. Care Med. 170, 987-993 (Pubitemid 39425695)
30. Bachmaier, K., Guzman, E., Kawamura, T., Gao, X., and Malik, A. B. (2012) Sphingosine kinase 1 mediation of expression of the anaphylatoxin receptor C5L2 dampens the inflammatory response to endotoxin. PLoS ONE 7, e30742
31. Farkas, I., Sárvári, M., Aller, M., Okada, N., Okada, H., Likó, I., and Liposits, Z. (2012) Estrogen receptor alpha and beta differentially mediate C5aR agonist evoked Ca(2+)-influx in neurons through L-type voltage-gated Ca(2+) channels. Neurochem. Int. 60, 631-639
32. Cui, W., Lapointe, M., Gauvreau, D., Kalant, D., and Cianflone, K. (2009) Recombinant C3adesArg/acylation stimulating protein (ASP) is highly bioactive: a critical evaluation of C5L2 binding and 3T3-L1 adipocyte activation. Mol. Immunol. 46, 3207-3217
33. Riedemann, N. C., Guo, R. F., Hollmann, T. J., Gao, H., Neff, T. A., Reuben, J. S., Speyer, C. L., Sarma, J. V., Wetsel, R. A., Zetoune, F. S., and Ward, P. A. (2004) Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis. FASEB J. 18, 370-372
34. Van Lith, L. H. C., Oosterom, J., Van Elsas, A., and Zaman, G. J. R. (2009) C5a-stimulated recruitment of beta-arrestin2 to the nonsignaling 7-transmembrane decoy receptor C5L2. J. Biomol. Screen. 14, 1067-1075
35. Zhang, X., Schmudde, I., Laumonnier, Y., Pandey, M. K., Clark, J. R., König, P., Gerard, N. P., Gerard, C., Wills-Karp, M., and Köhl, J. (2010) A critical role for C5L2 in the pathogenesis of experimental allergic asthma. J. Immunol. 185, 6741-6752
36. Gerard, N. P., Lu, B., Liu, P., Craig, S., Fujiwara, Y., Okinaga, S., and Gerard, C. (2005) An anti-inflammatory function for the complement anaphylatoxin C5a-binding protein, C5L2. J. Biol. Chem. 280, 39677-39680 (Pubitemid 41779098)
37. Huber-Lang, M. S., Younkin, E. M., Sarma, J. V., McGuire, S. R., Lu, K. T., Guo, R. F., Padgaonkar, V. A., Curnutte, J. T., Erickson, R., Ward, P. A. (2002) Complement-induced impairment of innate immunity during sepsis. J. Immunol. 169, 3223-3231 (Pubitemid 35013169)
38. Woodruff, T. M., Strachan, A. J., Dryburgh, N., Shiels, I. A., Reid, R. C., Fairlie, D. P., Taylor, S. M. (2002) Antiarthritic activity of an orally active C5a receptor antagonist against antigen-induced monarticular arthritis in the rat. Arthritis Rheum. 46, 2476-2485
39. Abe, M., Shibata, K., Akatsu, H., Shimizu, N., Sakata, N., Katsuragi, T., and Okada, H. (2001) Contribution of anaphyla- toxin C5a to late airway responses after repeated exposure of antigen to allergic rats. J. Immunol. 167, 4651-4660 (Pubitemid 32954346)
40. Baelder, R., Fuchs, B., Bautsch, W., Zwirner, J., Köhl, J., Hoymann, H. G., Glaab, T., Erpenbeck, V., Krug, N., and Braun, A. (2005) Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation. J. Immunol. 174, 783-789 (Pubitemid 40094273)
41. Lambrecht, B. N. (2006) An unexpected role for the anaphylatoxin C5a receptor in allergic sensitization. J. Clin. Invest. 116, 628-632 (Pubitemid 43326869)
42. Arumugam, T. V., Shiels, I. A., Strachan, A. J., Abbenante, G., Fairlie, D. P., and Taylor, S. M. (2003) A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats. Kidney Int. 63, 134-142 (Pubitemid 35463914)
43. Proctor, L. M., Arumugam, T. V., Shiels, I., Reid, R. C., Fairlie, D. P., and Taylor, S. M. (2004) Comparative anti-inflammatory activities of antagonists to C3a and C5a receptors in a rat model of intestinal ischaemia/reperfusion injury. Br. J. Pharmacol. 142, 756-764 (Pubitemid 38969670)
44. Woodruff, T. M., Arumugam, T. V., Shiels, I. A., Reid, R. C., Fairlie, D. P., and Taylor, S. M. (2004) Protective effects of a potent C5a receptor antagonist on experimental acute limb ischemia-reperfusion in rats. J. Surg. Res. 116, 81-90 (Pubitemid 38083288)
45. Woodruff, T. M., Arumugam, T. V., Shiels, I. A., Reid, R. C., Fairlie, D. P., and Taylor, S. M. (2003) A potent human C5a receptor antagonist protects against disease pathology in a rat model of inflammatory bowel disease. J. Immunol. 171, 5514-5520 (Pubitemid 37432841)
46. Johswich, K., Martin, M., Bleich, A., Kracht, M., Dittrich- Breiholz, O., Gessner, J. E., Suerbaum, S., Wende, E., Rheinheimer, C., and Klos, A. (2009) Role of the C5a receptor (C5aR) in acute and chronic dextran sulfate-induced models of inflammatory bowel disease. Inflamm. Bowel Dis. 15, 1812-1823
47. Jain, U., Woodruff, T. M., and Stadnyk, A. W. (2012) The C5a receptor antagonist PMX205 ameliorates experimentally induced colitis associated with increased IL-4 and IL-10. Br. J. Pharmacol. doi:10.1111/j.1476-5381.2012.02183.x
48. Manthey, H. D., Thomas, A. C., Shiels, I. A., Zernecke, A., Woodruff, T. M., Rolfe, B., and Taylor, S. M. (2011) Complement C5a inhibition reduces atherosclerosis in ApoE-/- mice. FASEB J. 25, 2447-2455
49. Woodruff, T. M., Crane, J. W., Proctor, L. M., Buller, K. M., Shek, A. B., de Vos, K., Pollitt, S., Williams, H. M., Shiels, I. A., Monk, P. N., and Taylor, S. M. (2006) Therapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration. FASEB J. 20, 1407-1417 (Pubitemid 44943849)
50. Fonseca, M. I., Ager, R. R., Chu, S. H., Yazan, O., Sanderson, S. D., LaFerla, F. M., Taylor, S. M., Woodruff, T. M., and Tenner, A. J. (2009) Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease. J. Immunol. 183, 1375-1383
51. Pavlovski, D., Thundyil, J., Monk, P. N., Wetsel, R. A., Taylor, S. M., and Woodruff, T. M. (2012) Generation of complement component C5a by ischemic neurons promotes neuronal apoptosis. FASEB J. 26, 3680-3690
52. Flierl, M. A., Rittirsch, D., Chen, A. J., Nadeau, B. A., Day, D. E., Sarma, J. V., Huber-Lang, M. S., and Ward, P. A. (2008) The complement anaphylatoxin C5a induces apoptosis in adrenomedullary cells during experimental sepsis. PLoS ONE 3, e2560
53. Fisette, A., Munkonda, M. N., Oikonomopoulou, K., Paglialunga, S., Lambris, J. D., and Cianflone, K. (2012) C5L2 receptor disruption enhances the development of diet-induced insulin resistance in mice. [E-pub ahead of print] Immunobiology doi:10.1016/j.imbio.2012.04.001
54. Wen, Y., Wang, H. W., Hu, X. F., Cianflone, K., Wei, J., Xia, Z., and Li, R. Z. (2008) [Role of progesterone in acylation stimulating protein-receptor C5L2 pathway in adipocytes and preadipocytes]. Zhonghua Yi Xue Za Zhi 88, 114-118
55. Francis, K., Lewis, B. M., Monk, P. N., and Ham, J. (2008) Complement C5a receptors in the pituitary gland: expression and function. J. Endocrinol. 199, 417-424
56. Roy, C., Roy, M. C., Gauvreau, D., Poulin, A. M., Tom, F. Q., Timofeeva, E., Richard, D., and Cianflone, K. (2011) Acute injection of ASP in the third ventricle inhibits food intake and locomotor activity in rats. Am. J. Physiol. Endocrinol. Metab. 301, E232-E241
57. Shukla, S. D., Velazquez, J., French, S. W., Lu, S. C., Ticku, M. K., and Zakhari, S. (2008) Emerging role of epigenetics in the actions of alcohol. Alcohol. Clin. Exp. Res. 32, 1525-1534
58. Monk, P. N., Bellows-Peterson, M. L., Smadbeck, J., Floudas, C. A., Kieslich, C. A., Morikis, D., and Woodruff, T. M. (2012) De novo protein design of agonists and antagonists of C5a receptors. Immunobiology 217, 1162-1163